UConn Team Develops Treatment for Fatty Liver Disease

Researchers at UConn have created a promising new therapy that could stop and even reverse fatty liver disease, a condition affecting billions globally with few current treatment options.

The innovative approach targets a master regulator in the liver that controls over 1,000 genes crucial for metabolic function.